Why We Are Collaborating

The University of Minnesota and Mayo Clinic rank as two of the top research institutions in the United States. Taken together, they manage $700 million in major research projects, and already have invested nearly a half-billion dollars in their respective biotechnology and medical genomics programs.

The health care and economic potential of biotechnology and medical genomics is significant, but so is the cost of development. Neither the University of Minnesota nor Mayo Clinic can successfully undertake such a broad and far-reaching initiative on its own. A Partnership was announced in April 2003 to undertake joint research projects involving scientists from both the University and Mayo Clinic.

The Minnesota Partnership for Biotechnology and Medical Genomics represents an initiative to bring together the state's two largest medical research institutions in an historic collaboration. The idea was born out of a desire by both institutions, together with the state, to move Minnesota bioscience research to a world-class and highly competitive level.

To learn more about Mayo Clinic and the University of Minnesota, visit the links below.

• About Mayo Clinic
• Genomics and Biotechnology at Mayo Clinic
• Mayo Clinic's Online Research Magazine “Discovery’s Edge”: Partnering for the Future
• About the University of Minnesota